No Data
Bairen Healthcare 2024 Annual Report
Summary of Bairen Healthcare\'s 2024 Annual Report
Bairen Healthcare\'s 2025 First Quarter Report
The business driven by cardiac valve replacement and repair treatments will lead to a 27% increase in net profit for Beijing Balance Medical Technology Co., Ltd. in 2024.
1. Beijing Balance Medical Technology Co., Ltd. achieved revenue of 0.502 billion yuan, a year-on-year increase of 35.41%; net income attributable to shareholders was 0.146 billion yuan, a year-on-year increase of 27.02%; 2. Benefiting from the launch of new products (transcatheter aortic valve system) and increased market demand, the revenue from the cardiac valve replacement and repair treatment Sector saw significant growth, with revenue of 0.229 billion yuan, a year-on-year increase of 64.28%.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Beijing Balance Medical Technology Co., Ltd. (688198.SH): The registration application for the interventive pulmonary valve and delivery system has been accepted.
On March 7, Gluonhui reported that Beijing Balance Medical Technology Co., Ltd. (688198.SH) announced that its self-developed interventional pulmonary valve and delivery system submitted a registration application and was officially accepted by the National Medical Products Administration's Medical Device Technology Review Center. The product adopts the company's unique leaf junction and bracket connection structural primary process design (patent number: 201910274554.3), achieving a connection between the leaf junction and bracket, eliminating stress concentration during the opening and closing of the leaf, while obtaining the same opening and closing mode and hemodynamic characteristics as the company's surgical biological valve. At the same time, the leaf tissue of this product continues to use the manufacturing process of the company's surgical valve.
